Kwonoh Park, MD, phD
Pusan National University Yangsan Hospital
4
4
1
N/A
0
3
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Yair Lotan, MD
University of Texas Southwestern Medical Center
Shared therapeutic areas:
Hailong Hu, MD,PhD
Tianjin Medical University Second Hospital
Shared therapeutic areas:
Jonathan Gamble, MD
University of Saskatchewan
Shared therapeutic areas:
Herui Yao, PhD
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Shared therapeutic areas:
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Jeffrey Skolnik, MD
Inovio Pharmaceuticals
Shared therapeutic areas:
Paul Crispen, MD
University of Florida
Shared therapeutic areas:
Anish Thomas, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Michael Offin, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Andrea B Apolo, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
REcommened Communication With Sympathy in Terminally Ill Cancer Patients Treated With Palliative Sedation
Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma
Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients
Comparison Between Initial Routine PICC and General IV Access in Terminally Ill Cancer Patients
All 4 trials loaded